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Abstract 
Ocular developmental disorders, including the group classified as Microphthalmia 
Anophthalmia and Coloboma (MAC) and inherited retinal dystrophies (IRDs) collectively 
represent leading causes of hereditary blindness. Characterized by extreme genetic and 
clinical heterogeneity, the separate groups share many common genetic causes, in particular 
relating to pathways controlling retinal and retinal pigment epithelial maintenance. In order to 
understand these shared pathways and delineate the overlap between these groups we 
investigated the genetic cause of an autosomal dominantly inherited condition of retinal 
dystrophy and bilateral coloboma, present in varying degrees in a large 5-generation family. 
By exome sequencing we identified a novel heterozygous mutation, n.37C>T, in the seed 
region of microRNA-204 (miR-204), which segregates with the disease in all affected 
individuals. We demonstrated by transcriptome analysis and other in vitro assays that this 
mutation determines significant alterations of miR-204 targeting capabilities. Moreover, we 
also demonstrated that miR-204 is necessary for proper function of photoreceptor cells as the 
down-regulation of miR-204 in medaka fish (Oryzias latipes) gives rise to an aberrant 
photoreceptor phenotype with reduced numbers of both cones and rods due to increased 
apoptosis, which leads to significant alterations of visual function. Finally, we demonstrated 
in vivo the pathogenic effect of the n.37C>T mutation by determining that the injection, in 
medaka fish, of a mutated miR-204 induced a phenotype consistent with that observed in the 
family. These data highlight the importance of miR-204 in regulation of ocular development 
and maintenance and provide the first evidence of its contribution to eye disease.  
 
Significance Statement 
MicroRNAs are key players in the regulation of gene expression. An understanding of human 
conditions caused by microRNA mutations provides insight into mechanisms of gene 
regulation as well as into the interplay between development and maintenance in tissue 
homeostasis. The eye represents a preferential target tissue of genetic diseases. Inherited 
retinal degenerations and developmental eye disorders are two separate groups that represent 
leading causes of blindness worldwide. Identifying underlying genetic causes of such 
conditions is important for diagnosis, counselling and potential therapy development. We 
identified a dominant mutation in microRNA-204 as the genetic cause of a unique phenotype 
of retinal degeneration and coloboma and thus highlight the importance of miR-204 as a 
master regulator of ocular development and normal maintenance. 
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Introduction 
The eye represents one of the preferential target tissues of genetic diseases. The main group 
of genetic disorders affecting the retina is represented by inherited retinal dystrophies (IRD) 
that include, among others, Retinitis Pigmentosa (RP), one of the leading causes of inherited 
blindness in the western population with a prevalence of 1:4000 (1). The loss of vision in 
severe retinal dystrophies is often a result of progressive loss or dysfunction of photoreceptor 
cells or retinal pigment epithelial (RPE) cells. Besides degenerative disorders, the eye is also 
the target of a number of developmental genetic disorders, among which the group classified 
as Microphthalmia Anophthalmia and Coloboma (MAC) feature major structural eye 
malformations. Both IRDs and MACs are characterized by an extremely high genetic 
heterogeneity. According to recent estimates, over 150 retinal dystrophy genes 
(http://www.sph.uth.tmc.edu/Retnet/home.htm) and over 25 MAC genes 
(http://www.omim.org) have been reported to date, including several that account for 
conditions in both groups. Many others remain to be identified for both conditions. 
  
MicroRNAs (miRNAs) are emerging as key players in the control of fundamental biological 
processes in both physiological and pathological conditions. They are single-stranded 
noncoding, short (20-25 nucleotide) RNAs that regulate gene expression through inhibiting 
translation of mRNAs or promoting their degradation. Their importance in regulating gene 
expression in retinal cells is highlighted by the high number of miRNAs that are 
preferentially expressed in the vertebrate retina (2–5).  Evidence indicates that miRNAs are 
important for development and maintenance of correct function within the eye, and in 
particular the retina (6–8). Mutations in miRNAs or their target genes may contribute to a 
range of ocular abnormalities. In this study we investigated the molecular basis for an 
unusual phenotype observed in a family with a history of varying degrees of retinal 
degeneration and MAC features (coloboma). We describe the identification of a dominant 
mutation in miR-204 and demonstrate the functional significance of this mutation to the 
retinal phenotype observed in this family. 
 
 
 
Results 
Clinical information 
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A diagnosis of bilateral coloboma and rod-cone dystrophy with or without cataract was made in 
9 individuals of a 5-generation family of Caucasian British descent. Family history suggested 
an autosomal dominant pattern of inheritance and full clinical examination demonstrated that 
the phenotype was not associated with extraocular manifestations.  
 
Individual V-1, aged 18 years, was diagnosed with retinal dystrophy and bilateral iris coloboma 
in early childhood. He had reduced visual acuities (LogMar 0.74 right, 0.84 left) and was 
registered partially sighted. Mild hypermetropic astigmatism was present (RE +1.75/+o.50 x 
100; LE +2.25/+0.50 x 85). Colour vision was seriously compromised bilaterally in City 
University Colour Vision Test (3rd edition, 1998) and Ishihara colour vision screening test (38 
plate edition, 1979). Bilateral iris colobomata with iridolenticular adhesions were present with 
no evidence of cataract (Fig. 1D). Dilated posterior segment examination revealed scattered 
retinal pigment epithelium (RPE) mottling with retinal atrophy, attenuation of the retinal 
vasculature and pale waxy discs bilaterally (Fig. 1E-F). Electroretinography revealed 
extinguished RE and LE responses to all conditions except a very slight light adapted flicker 
response (Fig. 1G); 4 years previously this had revealed evidence of a cone response that was 
now absent. The proband’s mother IV-I, aged 42 years, presented with a similar phenotype, 
having been diagnosed with bilateral iris colobomata and a progressive retinopathy in 
infancy. She underwent bilateral cataract surgery at the age of 30 years and suffered a retinal 
detachment in her LE. She was registered blind at age 30 and has hand movement vision in 
her RE and no perception of light in her LE. Bilateral pseudophakia and posterior capsular 
opacification gave a limited fundal view (Fig. 1B-C). Individual II-1, III-1, III-2 and III-3 
were all registered blind. All had bilateral iris coloboma and a slowly progressive retinal 
dystrophy leading to marked loss of vision in late childhood or early adult life. Notably, 
individual III-2 was also found to have congenital cataracts for which underwent right 
cataract surgery at aged 7 years.  
 
Identification of a miR-204 mutation by linkage analysis and exome sequencing. 
 
To identify possible chromosomal regions associated with the retinal dystrophy and iris 
coloboma phenotype in this family, parametric linkage analysis was performed for six 
individuals (Patients II-1, III-1, III-2, V-1, V-2 and V-3), which provided 8 informative 
meioses. This data achieved a maximal LOD score of 1.81 which falls below the level of 3.0 
required to confirm significance of linkage. The data was therefore analysed on the basis of 
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linkage exclusion for those regions with a LOD score less than -2. There were 4 regions 
remaining over 5Mb which had a LOD score of between -2 and 1.81 (Fig. S1). Subsequently, 
exome sequencing was performed on patients II-I and V-I to identify possible causal variants 
within the potential linked regions. This revealed 39 variant calls common to both patients. 
To prioritize the likely disease causing mutations we assumed a dominant model of 
inheritance and excluded homozygous changes. Following further filtering to exclude those 
variants reported in the Exome Variant Server of the National Heart, Lung, and Blood 
Institute Exome Sequencing Project (http://evs.gs.washington.edu/EVS/), dbSNP136, 1000 
genomes project (www.1000genomes.org), variants which had been previously seen within 
an in-house database of 244 exomes and those variants confirmed, by sanger sequencing, not 
to co-segregate with disease in the family resulted in a single novel candidate variant. The 
n.37C>T mutation identified in the microRNA MIR204 (reference sequence NR_029621) 
was an excellent candidate for further study. MiR-204 is preferentially expressed in the eye 
and several studies have determined its role in eye development (3)(9–11). Evidence of the 
critical function of miR-204 in eye development strongly suggests a pathogenic role for the 
mutation identified in this family. 
 
Sanger sequencing confirmed the MIR204 n.37C>T mutation segregates with the retinal 
dystrophy and coloboma phenotype in the family members that were tested (II-1, III-1, III-2, 
III-3, IV-1 and V-1) and absent in the non-affected individuals tested (V-2, V-3) (Fig. 2A). 
The mutation is positioned at the fourth nucleotide within the highly conserved 7-nucleotide 
seed region of the 5p arm of the precursor microRNA (annotated according to 
mirBase,http://mirbase.org (12)) (Fig. 2B). Co-inheritance of retinal dystrophy and MAC is 
considerably rare. Mutation analysis of an additional 21 cases of known retinal dystrophy 
with MAC with no family history identified no variants in miR-204. Screening of an 
additional cohort of 457 patients with isolated MAC and 672 patients with autosomal 
dominant retinal degeneration phenotypes revealed no novel mutations in miR-204.  
Moreover, this variant was not present in the control databases of the EVS or 1000 genomes 
project. 
 
 
 
The impact of the n.37C>T mutation on miRNA target recognition 
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As the MIR204 mutation identified in our family lies within the seed region of the 5p arm, 
and therefore in the stem region of pre-miR-204, we used the m-fold algorithm 
(http://mfold.rit.albany.edu/) (13) to assess how the mutation identified might alter the 
predicted RNA secondary structure of this microRNA. Although, the n.37C>T mutation 
introduced a base-pairing mismatch, the decrease in free energy value was small, no bulges 
were introduced into the RNA structure and the regions critical for Drosha processing of pri-
miRNA were not affected (14). Therefore, the n.37C>T mutation was not predicted to 
destabilise the secondary structure of pre-miR-204 (Fig. 2C). Since mutations in miRNA 
sequence have been previously reported to alter pre-miRNA processing (15), we examined 
the impact of the variant on the biogenesis of miR-204. Notably, the expression levels of both 
the miR-204 and pre-miR-204 species appeared largely unaffected by the n.37C>T mutation 
(15% increase and 9% decrease, respectively) compared to wild type (Fig. S2).  This would 
suggest an alternative mechanism for the pathogenesis of this dominantly inherited mutation.  
 
Since the mutation lies within the seed region of the mature miRNA, it was more likely that 
this change would affect recognition of target genes. This could occur through two different 
modalities, i.e., either impaired recognition of bona fide miR-204 targets (loss-of-function 
mechanism) or creation of novel aberrant target sites (gain-of-function mechanism). To 
evaluate the relative contribution of either of the above mechanisms, we carried out a 
microRNA target prediction with the TargetScan (www.targetscan.org) and Diana-microT 
(diana.cslab.ece.ntua.gr/microT/) tools using as query the miR-204 sequence containing the 
n.37C>T variant. Intriguingly, we found that the mutated miR-204 sequence was predicted to 
target a much higher number of mRNAs (n=1132) vs. the wild-type sequence (n=557) (Table 
S1). Only 135 mRNA were predicted to be targeted by both the wild-type (wt) and the 
mutated (mut) miR-204 sequence suggesting that the n.37C>T sequence variant could indeed 
cause a notable alteration of miR-204 targeting properties. Luciferase assays or real-time RT-
PCR assays on a subset of targets validated some of the above predictions in all examples 
tested (Fig. S2).  
 
Therefore, in order to obtain a more global assessment of the effect of the n.37C>T sequence 
variant in the miR-204 sequence, we carried out transcriptome analysis by RNAseq analysis 
in a human RPE cell line (ARPE-19) (16). In particular, we transfected the cells with miR-
204 mimics corresponding to either the wild-type (wt) or to the mutated (mut) sequence and 
compared the results obtained from their RNAseq transcriptome profiles. We found that the 
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number of significantly down-regulated genes vs. a negative mimic control (false discovery 
rate<0.05) was higher in mut-miR-204-transfected (n=2129) than in wt-miR-204-transfected 
(n=1487) ARPE-19 cells. More importantly, we observed that genes down-regulated in cells 
transfected with wt-mimics were significantly and specifically enriched for wt-miR-204 
targets (n=154; hypergeometric p-value=2.90E-60) and that, conversely, genes 
downregulated in cells transfected with mut-mimics were significantly and specifically 
enriched for mut-miR-204 targets (n=249; hypergeometric p-value=3.31E-47) (Fig. 3). We 
found that out of the 154 wt-miR-204 predicted targets displaying a statistically significant 
decrease of their expression levels vs. controls in wt-miR-204-transfected cells, only 48 
behaved similarly in mut-miR-204-transfected cells. On the other hand, out of the 249 mut-
miR-204 predicted targets displaying a statistically significant decrease of their expression 
levels vs. controls in mut-miR-204-transfected cells, only 72 displayed a similar trend in wt-
miR-204 transfected cells. Overall, these data confirmed that the n.37C>T mutation 
determines a significant alteration of miR-204 function by both generating a large number of 
novel and aberrant direct targets (gain-of-function mechanism) and by impairing the 
recognition of wild-type targets (loss-of-function mechanism).  
 
MiR-204 knockdown induces an aberrant photoreceptor phenotype in vivo 
MiR-204 has been described to have a significant role in eye development. We previously 
reported that knockdown of this microRNA in medaka fish was linked to microphthalmia, 
abnormal lens development and eye coloboma (9, 17). However, an involvement of miR-204 
in photoreceptor function was never described. To further support the pathogenic role of this 
miRNA in the phenotype observed in our family, we performed miR-204 inactivation in 
medaka fish using morpholino (Mo) oligonucleotides, as previously described (9, 17), and 
assessed the consequences in the differentiated retina.  
 
Comparison of the morphology of the differentiated retina of control and Mo-miR-204-
injected embryos revealed that morphant retinas displayed significant alteration in 
photoreceptor marker staining, which was more evident in ventral regions (Fig. 4A-D’).  In 
particular, we observed by immunofluorescence a significant reduction of rhodopsin-positive 
mature rod photoreceptors and of Zpr-1-positive mature cone photoreceptors (Fig. 4A-D’). 
The significant down-regulation of photoreceptor markers was also confirmed at the 
transcript level for both the Oryzias latipes (ol) olRho and olCrx genes (Fig. S3). The above 
defects were more evident in morphant embryos that also displayed coloboma, in which 
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photoreceptor cells were completely absent in the ventral retina. On the other hand, we did 
not observe in morphant fish any apparent alterations in the number of other retinal neuronal 
cells, as determined by expression analysis of olOtx2, olPax6 and olProx1 (Fig. S3).  
 
The above data indicate that miR-204 knockdown causes a significant reduction of 
photoreceptor cells in medaka fish. We considered whether this reduction could be due to 
either alteration of cell proliferation or to apoptosis. At the optic cup stage and during retinal 
differentiation, immunostaining for phosphorylated histone H3 (PH-3), a specific marker for 
cells in the M-phase of cell cycle, revealed no difference in the number of proliferating retinal 
cells in miR-204 morphants when compared to control embryos (Fig. 4F-H). In contrast, at 
the onset of photoreceptor cell differentiation (St30-33), a significant increase in the number 
of TUNEL-positive apoptotic cells was detected in the retinas of miR-204 morphants when 
compared to controls (Fig. 4I-K) thus suggesting that the reduction of photoreceptor cells in 
miR-204 morphant fish is mostly due to increased apoptosis. 
 
Finally, we performed a detailed analysis of photoreceptor function in miR-204 morphant 
larvae. We recorded flash electroretinogram (ERG) under scotopic conditions from both 
control and miR-204 morphant larvae. Notably, we observed a significant reduction of the 
amplitude of the b-wave in miR-204 morphant compared to control medaka larvae (n=30) 
(Fig. 4E). The amplitude reduction was consistently observed at all luminance values 
analyzed. These data indicate that the loss of photoreceptors caused by miR-204 knockdown 
determines a significant alteration of visual function.  
 
Injection of the n.37C>T mutated miR-204 causes severe ocular malformations associated 
with retinal dystrophy in vivo. 
To test in vivo the putative pathogenic effect of the miR-204 n.37C>T variation, we 
overexpressed a miR-204 mimic carrying the mutation (mut-miR-204) in medaka fish. 
Embryos injected with mut-miR-204 at the one-cell stage showed an aberrant eye phenotype 
(90 ± 5% of 1,500 injected embryos) from St19, corresponding to optic vesicle formation, 
onward. In particular, growth of the eye cup was significantly impaired and culminated at 
St38 in evident microphthalmia and optic coloboma (Fig. 5B). These phenotypic alterations 
were very different and much more severe with respect to those observed after 
overexpression in medaka of a wild-type miR-204 mimic only characterized by a modest 
microphthalmia (Fig. 5C). Moreover, to assess whether the n.37C>T variation also had an 
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effect on photoreceptor development, we analyzed the retinas of mut-miR-204 injected 
embryos at St.38 (n = 20 eyes). We observed a notable reduction of both rod and cone 
photoreceptor cells in mut-miR-204 overexpression in comparison to both wt-miR-204 and 
control injected embryos, as assessed by immunofluorescence analysis with an anti-
Rhodopsin and anti-Zpr-1 antibodies (Fig. 5D-I), respectively. Overall, the above data further 
confirm also in vivo that the n.37C>T variation significantly alters miR-204 function and then 
strengthen its pathogenic role in the complex phenotype observed in our family. Finally, 
these in vivo studies uncover, for the first time, the essential role of miR-204 in photoreceptor 
cell differentiation and function (Fig. 4 and 5). 
 
Discussion 
 
In this study we describe a five-generation family with an overlapping phenotype of inherited 
retinal dystrophy and optic fissure closure defect, iris coloboma. To elucidate the underlying 
molecular basis of this phenotype we undertook a combined linkage and exome sequencing 
approach identifying 4 potentially linked regions one of which, on chromosome 9q21, 
contained a novel heterozygous mutation in MIR204 (n.37C>T) that segregated with the 
phenotype observed in this family. Given the well-documented role of miR-204 in eye 
development, this mutation was a strong candidate for further investigation.   
 
MiR-204 has discrete and dynamic expression domains in the eye throughout development, 
being expressed in the RPE, neural retina, lens and ciliary body in fish, mouse and human (3, 
4, 10, 11, 18–20). A large body of evidence indicates that miR-204 plays a crucial role in the 
differentiation and function of all the ocular structures in which it is expressed. In vitro assays 
have shown that miR-204 may be involved in the correct differentiation and function of RPE 
cells (19, 21, 22). MiR-204 is also required for proper lens development (9, 10). We 
previously reported that this action is exerted through a complex cross-talk with the 
transcription factor Pax6, a ‘master regulator’ of eye development.  We found that while Pax6 
controls the expression of miR-204 (11), miR-204 can itself repress Pax6 through the 
targeting of the transcription factor Meis2 (10). Additional target genes that play a role in 
miR-204 action in lens differentiation are Ankrd13a (9), Sox11 (11) and Hmx1 (23). Finally, 
miR-204 controls the establishment of the proper dorsal-ventral axis and its inactivation was 
linked to coloboma in medaka fish (10).  
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In spite of its pervasive role in many aspects of ocular differentiation, miR-204 has not 
previously been reported to have an impact on photoreceptor function. Here, we demonstrate 
that knockdown of miR-204 function in medaka fish leads to progressive alteration and death 
of photoreceptor cells (Fig. 4). These alterations translate into profound abnormalities of 
photoreceptor and visual function as determined by ERG analysis (Fig. 4E). These data 
strongly indicate that miR-204 is also required for photoreceptor development and function. 
It is important to point out that miR-204 has not been previously reported to be significantly 
expressed in photoreceptor cells by RNA in situ hybridization assays (3, 11, 17, 18, 20). 
Therefore, it is possible to hypothesize either a cell autonomous action of this miRNA in 
photoreceptors, i.e., by being expressed at low levels at crucial developmental stages or a 
non-cell autonomous action. The latter may be mediated by the remarkable expression of 
miR-204 in the RPE (3, 11, 20). There are many examples of RPE-specific genes that play 
essential roles in photoreceptor function and whose mutations have pathogenic role in 
inherited retinal dystrophies (24, 25). In any case, the dissection of the molecular mechanisms 
through which miR-204 regulates photoreceptor function requires further studies.  
 
This is the first report of a pathogenic mutation within miR-204 identified as the cause of an 
ocular disease. It is supported by two main considerations. First, the n.37C>T mutation falls 
within the mature miR-204 seed region, which is considered to be the most essential 
sequence domain for target recognition and down-regulation (26). We demonstrate in vitro 
that this variation has an impact on target mRNA recognition (Fig. 3 and Fig. S2), which 
would be anticipated to lead to significant dysregulation of gene expression in eye tissues 
involving both natural or aberrantly generated miR-204 targets. Second, we demonstrated 
that the n.37C>T variation has a deleterious effect in vivo. In particular, we found that the 
overexpression of a miR-204 mimic carrying the n.37C>T mutation in medaka fish generates 
a dramatic eye phenotype characterized by gross malformations (including microphthalmia 
and coloboma) and photoreceptor abnormalities (Fig. 5). These results not only clearly 
support the deleterious role played by the n.37C>T mutation but also support its pathogenic 
role in the complex form of retinal dystrophy observed in the family we report in this study.  
 
We have identified a miR-204 mutation in a single large, family. We did not identify this 
mutation, or additional miR-204 mutations, in patients with either isolated IRD or MAC – 
that is phenotypes partly overlapping that observed in our family. However, the combination 
of retinal dystrophy and ocular coloboma is very rarely observed in clinical practice, in 
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particular when inherited as an autosomal dominant trait. It is therefore conceivable that this 
particular miR-204 mutation underlies the pathogenesis of an extremely rare ocular condition. 
This is in line with the limited number of reports of mutations within microRNAs associated 
with Mendelian disorders to date. The first report of mutations within a miRNA contributing 
to a disease phenotype was by Mencía et al., who identified two point mutations within the 
seed region of miR-96, which segregated with the affected patients from two separate 
Spanish families with autosomal dominant progressive hearing loss (27). The resulting 
mutations directly affected the miR-96 biogenesis and resulted in a significant reduction in 
the silencing of target genes. Soldà et al. reported a mutation in the 3p arm of MIR96 in a 
family with non-syndromic inherited hearing loss (15). This mutation was found to impair 
correct maturation of miR-96 leading to a significant decrease in the expression level of the 
mature 3p and 5p microRNA arms. The only other example of a microRNA with point 
mutations being associated with a Mendelian disorder is represented by MIR184. Hughes et 
al. identified a mutation in the central nucleotide of the seed region of MIR184 as the cause of 
keratoconus and early-onset anterior polar cataracts in a large Irish family (28). Iliff et al. 
reported the same mutation as the cause of EDICT syndrome, an autosomal dominant anterior 
segment dysgenesis syndrome characterized by endothelial dystrophy, iris hypoplasia, 
congenital cataract and stromal thinning (29). A further two novel heterozygous substitution 
variants, neither of which were located within the seed region, were later identified in 
MIR184 in two patients with isolated keratoconus (30). This is also the first report of a 
microRNA mutation with a causative role in inherited retinal dystrophies in patients as, to 
date, microRNAs have been linked to such diseases only in mouse (31).  
 
There are several reasons to explain the paucity of genetic diseases caused by miRNA 
mutations. First, given their shortness it is expected that the number of potential mutations 
affecting miRNA mature sequences will be significantly lower when compared to that of 
mutations falling within functional sequence elements of protein coding genes. Second, given 
the fact that each miRNA can target hundreds of different genes, mutations affecting critical 
nucleotides of mature sequences may give rise to phenotypes that depend on the target 
specificity affected by each mutation. Mutations altering miRNA function may not only be 
localized within their mature sequences but also in their binding sites within the 3’-UTR of 
target genes, as described in the cases of spastic paraplegia (32) and X-linked 
chondrodysplasia (33). Such mutations in the 3’ UTR would be expected to selectively affect 
specific aspects of miRNA actions and consequently to give rise to disease phenotypes that 
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will differ from those observed when mutations lie in the miRNA sequence itself. The 
assessment of the true impact of 3’-UTR mutations on genetic disorders will require analysis 
of gene regions thus far neglected in mutation screens.  
 
The n.37C>T mutation results in an autosomal dominantly inherited phenotype and thus 
could act either through loss-of-function (i.e. by impairing recognition of wild-type miR-204 
targets) or gain-of-function (by creating novel aberrant recognition sites in genes that should 
not normally be targeted by miR-204) mechanisms. We hypothesize that the gain-of-function 
mechanism exerts a predominant role for the following three reasons. First, both 
bioinformatic predictions and transcriptome studies indicate that the n.37C>T mutation is 
able to generate a much larger dataset of predicted targets as compared with the wild-type 
miR-204 mature sequence. Second, the injection in medaka fish of the mutated miR-204 
leads to a striking eye phenotype, much more severe than that obtained with injection of the 
wild-type miR-204. Finally, there are previous clinical data that seem to further exclude 
haploinsufficiency. MiR-204 is located within intron 8 of the transient receptor potential 
(TRP) channel gene, TRPM3 on chromosome 9q21.12. Deletions within 9q21 and those 
specifically encompassing the TRPM3 gene have not been reported to cause ocular 
phenotypes, instead features of mental retardation, epilepsy, speech delay, autistic behaviour 
and moderate facial dysmorphology (34–37). Deletion of this region has been described in 
association with an autism phenotype in a family in which a paternal deletion of exons 1–9 of 
TRMP3, that included MIR204, was shared by two affected sons and an unaffected daughter 
who were not described to have an ocular phenotype or visual symptoms. Furthermore, at 
least 30 patients with deletions in this region are listed on the Decipher database, a web-based 
resource and database of genomic copy number variation data from analysis of patient DNA; 
none is described with coloboma or retinal disease although one had optic nerve hypoplasia. 
Altogether, the above data indicate that the n.37C>T mutation mostly acts with a gain-of-
function mechanism although we cannot exclude that the loss of some miR-204 wild-type 
targets may still contribute to the phenotype observed in our family. 
 
Based on the above observations, we hypothesize that miR-204 is likely to play a key role in 
the pathogenesis of human eye diseases not only by means of different mutations in its 
mature sequence but also potentially through variation in recognition sites in some of its most 
relevant targets.  
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In summary, we have identified a new genetic cause for the pathogenesis of complex forms 
of eye diseases, particularly characterized by the combination of retinal dystrophy and 
developmental abnormalities. Our findings contribute to highlight miR-204 as a new putative 
“master regulator” of eye development, and in particular have been instrumental in 
uncovering its newly identified role in photoreceptor survival and function. Finally, our 
results shed further light on the recognition of the role of miRNAs as primary pathogenic 
agents in human genetic diseases. 
 
Materials and Methods 
Subjects 
A single 5-generation family with a highly unusual and visually disabling phenotype consisting 
of retinal dystrophy, and bilateral iris coloboma presented at the retinal and genetic clinic of the 
Manchester Royal Eye Hospital (Manchester, UK). A total of 9 family members exhibited a 
similar phenotype (6 female and 3 male) (Fig. 1A). To elucidate the molecular basis of this 
phenotype we enrolled 8 family members for clinical and molecular genetic analysis, 
including 6 affected individuals. Ethical approval and informed consent was obtained from all 
study participants. The research adhered to the tenets of the Declaration of Helsinki. 
 
Disease status was determined by a full medical, ophthalmic and family history combined 
with clinical examination and electrophysiological evidence in proband V-1, and his mother, 
patient IV-1. Medical records for other family members were reviewed with the patients’ 
written consent. Ophthalmic examination included anterior segment examination by slit lamp 
biomicroscopy with evaluation of anterior chamber depth using the Von Herrick method, intra-
ocular pressure measurements, and dilated fundus examination and photography. Optical 
coherence tomography (OCT) for retinal thickness assessment using the Heidelberg spectral-
domain OCT (Heidelberg engineering) was performed with autofluorescence and colour 
imaging. Full-field flash electroretinograms (ERG) were also carried out in individual V-1. 
Individual IV-1 underwent ERG testing in the 1980s.  ERGs were recorded following the 
standards of the International Society for Clinical Electrophysiology of Vision (ISCEV) (38). 
Both scotopic rod-driven responses and cone-driven photopic single flash and 30-Hz flicker 
stimuli were recorded sequentially. 
 
 
Linkage analysis 
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Genome-Wide SNP analysis was carried out using the Affymetrix Genome-Wide SNP6.0 
microarray.  Genotypes were generated using the genotyping console software provided by 
Affymetrix using the Birdseed V2 algorithm and a confidence threshold of 0.005. A subset of 
SNPs were selected for linkage analysis based on having a MAF of 0.2 in order to reduce the 
problems associated with linkage disequilibrium when using dense marker sets. Parametric 
multipoint linkage analysis was performed using Merlin 
(http://www.sph.umich.edu/csg/abecasis/merlin/index.html) using a dominant model with full 
penetrance.  
 
Exome sequencing and variant prioritization  
Whole-exome target enrichment and sequencing were performed on 3 ug of DNA extracted 
from peripheral blood of two affected family members, proband V-I and patient II-I (Fig. 
1A). For patient V-I enrichment was performed using the SureSelect Human All Exon v.1 
Enrichment kit (Agilent Technologies, Santa Clara, CA, USA) for the Illumina HiSeq system, 
according to the manufacturer’s protocol. Sequencing was carried out on a HiSeq 2000 
sequencer (Illumina Inc, San Diego, CA, USA), following the manufacturer’s protocols by 
Hong Kong Co. Hong Kong. Sequence data were mapped to the hg19 reference human 
genome using BWA software. Variants were called using GATK v2.4.7 software then filtered 
for those SNPs with ≤ 5X coverage. Approximately 4 GB of sequence mapped uniquely to 
the genome reference hg19, with 69.4% of the exome covered at 20-fold or higher. SNPs and 
insertions/deletions were initially annotated to genes using Ensembl v68 and the functional 
consequences were then defined against an in-house list of Refseq transcripts 
(www.ncbi.nlm.nih.gov/refseq). Using Ensembl’s defined consequence hierarchically system, 
the highest impacting consequence for a variant in a gene was retained.  To find likely 
pathogenic changes an in-house hierarchy system of functional consequence was used to 
prioritize variants, as detailed in (39). Briefly, variants were filtered out if they were present 
in dbSNP136 (unless seen in the Human Gene Mutation Database (HGMD), 
http://www.hgmd.org), if seen more than once in our in-house variant database, present in the 
1000 genomes project or the exome variant server (EVS). Novel changes were analysed 
further using the in-silico tools SIFT (Sorting Intolerant from Tolerant) (40), PolyPhen-2 
(41), and splicing prediction tools via the software Alamut (Interactive Biosoftware, LLC) to 
assess their pathogenicity.  
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For patient II-1, enrichment was performed using TargetSeq exome enrichment (Life 
Technologies, Carlsbad, CA, USA) following the manufacturer’s protocols. Emulsion PCR 
was conducted on the resultant enriched sample library and the sample was run indexed with 
unrelated samples on a SOLiD 5500xl sequencer following the manufacturer’s protocols. 
Sequence data were mapped to the hg19 reference human genome using Lifescope software. 
Approximately 4.5 GB of sequence mapped uniquely to the genome reference hg19, with 
68.2% of the exome covered at 20-fold or higher. Variants were called using a combination 
of the Lifescope software suite and SAMtools (freeware)(42) and then filtered for those SNPs 
with ≤ 5X coverage. SNPs were annotated and filtered as for patient V-I.  
 
PCR and Sanger sequencing to confirm novel variants 
Mutations identified in candidate genes by exome sequencing were confirmed by direct 
Sanger sequencing. PCR amplification of MIR204 was performed using the oligonucleotide 
primers listed in Table S2. Amplicons were sequenced using the BigDye Terminator v3.1 
system (Life Technologies) and analysed on an ABI 3730 DNA Analyser (Life 
Technologies).  
 
Cell transfections, RNA extraction and analysis  
ARPE-19 cells (16) were cultured at 37ºC in a humidified chamber supplemented with 5% 
CO2. Cells were seeded at 135000 cell/mL in 24-multi well plates and transfected with DNA 
constructs using the PolyFect transfection reagent (Qiagen) according to the manufacturer’s 
instructions. Total RNA was extracted using TRIZOL (Invitrogen) according to the 
manufacturer’s instructions and used for subsequent RNA-Seq-based profiling as previously 
described (43). RNA-Seq libraries were generated following the standard Illumina RNASeq 
protocol and sequenced using an Illumina HiSeq 1000 at the Next Generation Sequencing 
Facility of the Telethon Institute of Genetics and Medicine. Differential expression analysis 
of read counts was performed using the Generalized Linear Model approach for multiple 
groups implemented in the Bioconductor package "edgeR" (44, 45). The expression cutoff 
used was 1 CPM (Count Per Million) in at least three samples. 
 
HeLa cell and H36CE human lens epithelial (46) cell lines were cultured at 37ºC in a 
humidified chamber supplemented with 5% CO2 as previously described (9). Cells were 
seeded at 135000 cell/mL in 24-multi well plates and transfected with DNA constructs using 
the PolyFect transfection reagent (Qiagen) according to the manufacturer’s instructions. 
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pGL3-TK plasmids containing the 3’ UTR of the human MEIS2 and ANKRD13A mRNAs 
and psiUx plasmid constructs containing the wild-type or the mutated form of precursor 
sequences of hsa-miR-204 were generated and used in luciferase assays as previously 
described (9, 10). For quantitative RT-PCR experiments, H36CE cells were transfected with 
psiUx plasmid constructs containing the wild-type or the mutated form of precursor 
sequences of hsa-miR-204 and qRT-PCR were performed as described (9). Each assay was 
performed in duplicate and results are presented as mean ± SD for at least three independent 
assays. The primers used for the qRT-PCR are listed in Table S3. 
 
Quantitative RT-PCR to assess biogenesis of miR-204 
psiUx plasmid constructs containing the wild-type or the mutated form of precursor 
sequences of hsa-miR-204, generated as previously described (9, 10), were transfected into 
ME-180 (47) cells using Lipofectamine 2000 (Life Technologies) according to the 
manufacturer’s instructions. RNA was extracted after 24 h, using the miRNeasy isolation kit 
(Qiagen).  Reverse transcription was performed using the Taqman® MicroRNA reverse 
transcription kit (Life Technologies) with specific custom designed stem loop RT primers for 
the mature  mir-204 and precursor mir-204 products (Table S4). Real-Time PCR was 
performed using FastStart Universal SYBR Green Master mix (Roche Applied Sciences) and 
miRNA specific forward and reverse primers listed in Table S4. Expression of U6 snRNA, 
used to normalise RNA input, was assessed using a TaqMan® Small RNA assay (Life 
Technologies), according to the manufacturer’s instructions. Expression values were 
generated using a standard curve method.  In all experiments miR-98 was used as an internal 
control to normalise for transfection efficiency. Each assay was performed in triplicate and 
data is presented as the mean ±SD of three individual experiments.     
 
Medaka stocks and miR-204 mimic morpholino injections.  
The Cab-strain of wild-type medaka fish (Oryzias latipes) were maintained as previously 
described (9). Embryos were staged according to Iwamatsu et al. (48). Morpholinos (Gene 
Tools, LLC, OR) and both wild-type and mutated miRIDIAN Dharmacon miR-204 mimics 
were designed and injected into one-cell fertilized embryos as previously described (10). All 
fish studies were conducted in strict accordance with the institutional guidelines for animal 
research and approved by the Italian Ministry of Health. 
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RNA in situ hybridization and immunofluorescence.  
Whole-mount RNA in situ hybridizations were performed, photographed and sectioned (25-
m vibratome sections) as described by Conte et al. (17). Digoxigenin-labeled anti-sense and 
sense riboprobes for olCrx, olPax6, olOtx2 and olRhodopsin were used (17). Medaka 
embryos were cryostat-sectioned (12-m) and immuno-labeling was performed as previously 
described (17) using  mouse monoclonal antibodies to Rhodopsin (Rho) (1:2000, Sigma) and 
Zpr-1 (1:2000, ZIRC) and  the rabbit polyclonal antibody to Prox1 (1:200, Chemicon). 
Alexa-488-conjugated goat α-mouse and goat α-rabbit (1:1000, Invitrogen) secondary 
antibodies were used. For the cell proliferation analysis, rabbit α-phospho-histone H3 (1:100, 
Cell signaling Technology) and peroxidase-conjugated anti-rabbit antibody (1:200, vector 
laboratories) were used followed by DAB staining as previously described (49). Confocal 
images were acquired using the Zeiss microscope, LSM 710. 
 
Detection of apoptotic cell death 
The extent and distribution of apoptotic cell death was determined by TdT-mediated dUTP 
nick end labeling (TUNEL), using the In Situ Cell Death Detection Kit, POD (Roche) 
following the manufacturer’s protocol.  
 
Fish Electroretinogram. 
Electroretinograms (ERGs) were recorded as described previously (50). Briefly, medaka 
larvae were dark adapted for 30 min. For recording, a reference electrode was placed in a 1% 
agarose in ddH2O. The larva was placed dorsal-up on a moist paper covering the reference 
electrode. The recording electrode with a tip diameter of approximately 20 μm was filled with 
buffer E3 (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4) and placed 
on the cornea of the larva. Light stimuli of 100 ms with interstimulus intervals of 7 s were 
applied. The light stimulus intensity was 665 lux. 
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Figure legends 
 
 
Fig. 1. Ocular phenotype of family with inherited retinal dystrophy and iris coloboma. 
A) Pedigree of family. The proband is denoted by an arrow. * denotes patients affected with 
retinal dystrophy and coloboma who underwent exome sequencing. ● denotes all patients 
where DNA was available for testing.  B-D) Slit lamp biomicroscopy photographs of affected 
family members. Right (B) and left eye (C) of patient IV-I demonstrating inferior iris 
coloboma and iridolenticular adhesions. Left eye of patient V-I (D) shows inferior iris 
coloboma and evidence of iridolenticular adhesions but no evidence of significant cataract. E) 
Fundus photograph of the retina of patient V-1, showing extensive chorioretinal atrophy and 
retinal pigment epithelium mottling. F) Cross-sectional OCT image taken with the Heidelberg 
Spectralis scanning laser ophthalmoscope with enhanced depth imaging features. Retinal 
thinning as a result of loss of inner and outer photoreceptor segments is evident. There is 
focal disturbance of the retinal pigment epithelium layer.  G) Electroretinogram of left and 
right eye of patient V-1 demonstrating extinguished responses to all conditions except a very 
slight light adapted flicker response (upper part of diagram). Shaded areas represent 95% 
confidence intervals 
 
 
Fig. 2. The novel miR-204 mutation (n.37C>T) identified in a family with autosomal 
dominant retinal dystrophy and coloboma. A) Electropherograms showing the 22-nt 
mature sequence of mir-204. Patient sequence (top) contains the heterozygous mutation 
(n.37C>T), which segregated amongst affected individuals and the wild-type sequence 
(bottom) observed in unaffected individuals. The boxed sequence indicates the 7bp seed 
region. B) Multiple species alignment showing segment of the mir-204 sequence, including 
the 5p arm, obtained using CLUSTALW software. The human mutation at nucleotide 
position +37 is indicated in red, underlined sequence denotes the seed region. Hsa-Homo 
sapiens, ptr-Pan troglodytes, ggo-Gorilla gorilla, mml-Macaca mulatta, bta-Bos Taurus, rno-
Rattus norvegicus, mmu-Mus musculus, gga-Gallus gallus, fru-Fugu rubripes, mdo-
Monodelphis domestica, pma-Petromyzon marinus C) Predicted secondary structures of 
wild-type and mutant (n.37C>T) miR-204 precursors obtained using the m-fold algorithm. 
The nucleotide mutated in the family is indicated in blue and underlined.  
 
23 
 
Fig. 3. The n.37C>T sequence variation confers altered targeting capabilities to miR-
204, as assessed by transcriptome analysis. (A-D) Volcano plots depicting the results of 
RNA-Seq experiments carried out in ARPE-19 cells transfected with either wt-miR-204 (A-
B) or mutated (mut)-miR-204 mimics (C-D). X-axis, expression fold changes (on a log2 
scale) vs. control ARPE-19 cells (i.e., negative mimic transfected). Y-axis, statistical 
significance of expression changes represented as False Discovery Rate (FDR) values on a 
log10 scale. The black horizontal line indicates FDR=0.05 and the black vertical lines the 
10% expression fold change thresholds chosen to identify genes showing significant 
expression changes. Red dots indicate the genes that show statistically significant down-
regulation in each experiment. Green dots indicate the genes that show statistically significant 
up-regulation in each experiment. Grey dots represent genes that do not display significant 
expression changes. Black dots in (A) and (C) represent genes that are predicted to be targets 
of the wt-miR-204 whereas in (B) and (D) represent genes that are predicted to be targets of 
the mut-miR-204, i.e., carrying the n.37C>T variation. There is a statistically significant 
enrichment vs. control of, respectively, wt-miR-204 targets in the genes down-regulated in 
cells transfected with a wt-miR-204 mimic (A) and of mut-miR-204 targets in the genes 
down-regulated in cells transfected with a mut-miR-204 mimic (D), as determined by 
hypergeometric analysis. 
  
 
 
Fig. 4. Loss of function of miR-204 has a deleterious effect on photoreceptor 
maintenance and function in vivo. Representative frontal eye sections of St38 control (A,C) 
and Mo-miR-204–injected (B,D) medaka fish embryos immunostained with anti-Rhodopsin 
and Zpr-1 antibodies (green). Sections are counterstained with DAPI (blue). We observed a 
significant reduction in the intensity of rhodopsin and Zpr-1 staining in Mo-miR-204–
injected medaka fish, compared to controls.  A’-D’ are higher magnifications of the areas 
marked by the white dashed boxes in A-D. E) Intensity response curves of mean b-wave 
amplitude (± SEM) of control and Mo-miR-204 injected larvae (n=30). The b-wave  
amplitudes of morphant larvae  are significantly smaller respect to controls over the 5 units of 
intensity tested. (F-H) Cell proliferation is not altered in miR-204 morphant embryos. (F, G) 
Frontal vibratome sections of St30 control and Mo-miR-204 injected embryos 
immunostained with antiphospho-histone H3 (P-H3) antibodies. (H) Quantification of PH3-
positive cells in the retina of the control or Mo-miR-204 injected embryos at different 
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embryonic stages as indicated. No significant changes were detected between morphants and 
controls. Red arrows, P-H3-positive cells. (I-K) Frontal vibratome sections of TUNEL-
stained control and miR-204 morphant embryos. I-J) A significant increase of photoreceptor 
cell death in miR-204 morphant eyes was observed when compared to control as also 
illustrated in the inset that represents a higher magnification of the area marked by the dashed 
box in D. (K) Quantification of TUNEL-positive cells in the retina of control or Mo-miR-
204-injected embryos at different embryonic stages; blue arrows, TUNEL-positive cells; *** 
=P<0.0001 in χ2 tests. Other abbreviations: OS, Outer Segment of photoreceptors; ONL, 
Outer Nuclear Layer; INL, Inner Nuclear Layer. Scale bars: 20 μm. 
 
Fig. 5. The n.37C>T miR-204 mutation has a deleterious effect in vivo. (A-C)  Bright-
field microscopy images of lateral views eyes from control- (A), mut-miR-204- (B) and wt-
miR-204- (C) injected embryos.  Representative frontal eye sections, immunostained with an 
anti-Rhodopsin (D-F; green) and ZPR-1 (G-I; green) antibodies, from st38 control (D,G), 
mut-miR-204-injected (E,H) and wt-miR-204-injected (F,I) medaka fish. Sections are 
counterstained with DAPI (blue). We observed a significant reduction in the staining of both 
photoreceptor rods and cones in mut-miR-204–injected medaka fish as compared with 
control and wt-miR-204-injected animals. 
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